Recombinant Haemophilus parasuis serovar 5 ATP synthase subunit beta (atpD)

What is ATP synthase subunit beta (atpD) in H. parasuis and what is its functional significance?

ATP synthase subunit beta (atpD) is a critical component of the F1F0-ATP synthase complex in H. parasuis, responsible for ATP synthesis during oxidative phosphorylation. This enzyme utilizes the proton motive force across the bacterial membrane to catalyze the conversion of ADP and inorganic phosphate to ATP. In H. parasuis, genomic analysis has confirmed that the bacterium generates ATP through both fermentation and respiration pathways, with an intact TCA cycle for complete oxidation of glucose derivatives .

The atpD subunit contains the catalytic nucleotide-binding domains essential for ATP synthesis. Based on sequence analysis and comparison with the Haemophilus ducreyi atpD protein, the H. parasuis atpD likely contains conserved Walker A and B motifs responsible for nucleotide binding and catalysis . Unlike some other Haemophilus species (H. influenzae, H. ducreyi, and H. somni) that have deficiencies in their TCA cycle, H. parasuis maintains a complete cycle, making ATP synthesis particularly important for its energy metabolism .

ATP synthase functionality is especially crucial during infection when the bacterium must adapt to changing host environments and nutrient availability. The protein's high degree of conservation across bacterial species reflects its fundamental importance in bacterial survival and metabolism.

How is recombinant H. parasuis serovar 5 atpD typically expressed in laboratory settings?

Recombinant expression of H. parasuis serovar 5 atpD typically employs prokaryotic expression systems, with E. coli being the preferred host organism. The methodological approach involves several critical steps that must be optimized for successful expression:

• Gene Amplification and Cloning: The atpD gene is amplified from H. parasuis serovar 5 genomic DNA using PCR with specific primers designed based on the published genome sequence. The amplified gene is then cloned into an expression vector containing a strong inducible promoter (typically T7), an affinity tag sequence (commonly His-tag), and appropriate selection markers.

• Expression Optimization: Several parameters require optimization, including:

  • Induction temperature (typically 16-37°C, with lower temperatures often favoring soluble protein production)

  • Inducer concentration (IPTG at 0.1-1.0 mM)

  • Duration of induction (4-24 hours)

  • Media composition and cell density at induction

• Protein Solubility: ATP synthase components can form inclusion bodies when overexpressed. Strategies to enhance solubility include:

  • Co-expression with molecular chaperones (GroEL/GroES)

  • Fusion with solubility-enhancing tags (SUMO, MBP)

  • Optimization of growth and induction conditions

The full-length atpD protein typically has a molecular weight of approximately 50-52 kDa, similar to the H. ducreyi homolog . Expression yields generally range from 5-15 mg/L of bacterial culture, with variation depending on the specific expression conditions and strain used.

What are the optimal methods for purifying recombinant H. parasuis atpD?

Purification of recombinant H. parasuis atpD requires a systematic approach to ensure high purity while maintaining protein structure and function:

• Cell Lysis: Bacterial cells are typically disrupted using:

  • Sonication with pulsed cycles to prevent overheating

  • French press for larger-scale preparations

  • Chemical lysis using lysozyme (1 mg/mL) followed by detergent treatment

• Initial Clarification: The lysate is clarified by centrifugation at high speed (20,000-30,000 × g) to remove cell debris.

• Affinity Chromatography: For His-tagged atpD, immobilized metal affinity chromatography (IMAC) using Ni-NTA resin is the primary purification step:

  • Binding in buffer containing 20-50 mM imidazole to reduce non-specific binding

  • Washing with increasing imidazole concentrations (50-100 mM)

  • Elution with higher imidazole concentrations (250-500 mM)

• Secondary Purification: Additional chromatography steps may include:

  • Ion exchange chromatography (typically anion exchange on Q sepharose)

  • Size exclusion chromatography for final polishing and buffer exchange

  • Removal of endotoxin for samples intended for immunological studies

• Buffer Optimization: Typical buffer compositions include:

  • 20-50 mM Tris-HCl or phosphate buffer (pH 7.5-8.0)

  • 100-300 mM NaCl to maintain solubility

  • 5-10% glycerol as a stabilizing agent

  • 1-5 mM reducing agent (DTT or β-mercaptoethanol)

• Quality Control: The purified protein should be assessed for:

  • Purity by SDS-PAGE (typically >85%)

  • Identity by Western blotting or mass spectrometry

  • Structural integrity by circular dichroism or thermal shift assays

• Storage Considerations: Similar to other recombinant proteins, H. parasuis atpD should be stored with 5-50% glycerol at -20°C/-80°C for long-term stability, avoiding repeated freeze-thaw cycles .

What methodological approaches can be used to evaluate the immunogenicity of recombinant H. parasuis atpD?

Evaluating the immunogenicity of recombinant H. parasuis atpD requires a comprehensive approach involving both in vitro and in vivo methods:

• Animal Immunization Studies:

  • Mouse models: Inbred mice (BALB/c or C57BL/6) can be immunized with purified recombinant atpD with appropriate adjuvants.

  • Pig models: As the natural host, pigs provide the most relevant model, especially for evaluating protective efficacy.

  • Immunization protocols typically involve 2-3 doses at 2-3 week intervals, with various adjuvant formulations.

• Humoral Immune Response Analysis:

  • ELISA to measure antigen-specific IgG, IgA, and IgM titers

  • Western blot analysis to confirm antibody specificity

  • Subclass analysis (IgG1/IgG2c ratio in mice, IgG1/IgG2 in pigs) to determine Th1/Th2 bias

  • Functional antibody assays (opsonophagocytosis, complement-mediated killing)

• Cellular Immune Response Evaluation:

  • Lymphocyte proliferation assays using PBMCs stimulated with recombinant atpD

  • ELISpot assays to enumerate IFN-γ, IL-4, or IL-17-producing cells

  • Flow cytometry to assess T-cell activation markers and intracellular cytokine production

  • Measurement of cytokine profiles (IFN-γ, IL-17A, TNF, IL-4) as observed with other H. parasuis antigens

• Protection Assessment:

  • Challenge studies in appropriate animal models

  • Bacterial load determination in tissues (lungs, joints, brain)

  • Clinical scoring of disease symptoms and severity

  • Histopathological examination of affected tissues

These methodological approaches would need to be adapted based on the specific research question and available resources. The inclusion of appropriate positive controls (such as known protective antigens) and negative controls is essential for accurate interpretation of results.

How can researchers design expression systems for optimizing yield and solubility of recombinant H. parasuis atpD?

Designing expression systems for recombinant H. parasuis atpD presents several challenges that can be addressed through systematic optimization:

• Codon Optimization:

  • Analysis of H. parasuis codon usage compared to E. coli

  • Optimization of rare codons without altering amino acid sequence

  • Removal of potential RNA secondary structures that might impede translation

  • Elimination of internal Shine-Dalgarno-like sequences

• Vector Selection:

  • Tightly regulated expression vectors (pET series, pBAD) to control basal expression

  • Vectors with different promoter strengths (T7, tac, araBAD)

  • Incorporation of appropriate fusion tags:

    • N-terminal tags: His6, GST, MBP, SUMO, TrxA

    • C-terminal tags: His6, Strep-tag II

  • Inclusion of precision protease cleavage sites for tag removal

• Host Strain Selection:

  • BL21(DE3) and derivatives for T7-based expression

  • Rosetta or CodonPlus strains to supply rare tRNAs

  • SHuffle or Origami strains for enhanced disulfide bond formation

  • Arctic Express for low-temperature expression with cold-adapted chaperones

• Expression Condition Optimization:

  • Temperature screening (37°C, 30°C, 25°C, 18°C, 15°C)

  • Inducer concentration gradient

  • Media composition:

    • Rich media (LB, 2×YT, TB)

    • Defined media for controlled growth

    • Supplementation with glucose, glycerol, or amino acids

  • Cell density at induction (OD600 of 0.5-1.0)

  • Duration of induction (4h, 8h, overnight)

• Solubility Enhancement Strategies:

  • Co-expression with molecular chaperones (GroEL/GroES, DnaK/DnaJ/GrpE)

  • Addition of solubility enhancers to growth media:

    • Osmolytes (sorbitol, glycine betaine)

    • Mild detergents (Triton X-100 at low concentrations)

    • Low concentrations of ethanol or glycerol

  • Autoinduction media for gradual protein expression

By systematically testing these variables in small-scale expression trials before scaling up, researchers can identify the optimal conditions for producing soluble, functional recombinant H. parasuis atpD in quantities sufficient for structural, immunological, and biochemical studies.

What is the potential of atpD as a subunit vaccine candidate against H. parasuis infections?

Evaluation of atpD as a subunit vaccine candidate against H. parasuis requires consideration of several factors that influence its potential efficacy:

• Conservation Analysis:

  • Sequence conservation of atpD across the 15 known H. parasuis serovars is generally high due to its essential function, suggesting potential cross-protection.

  • Analysis of field isolates is necessary to confirm conservation in clinically relevant strains.

  • Identification of surface-exposed regions that may contain protective epitopes.

• Immunogenicity Assessment:

  • ATP synthase components from other bacteria have demonstrated immunogenicity in various models.

  • The ATP synthase complex plays a fundamental role in energy metabolism, which may limit variation and immune evasion.

  • Prior studies with other H. parasuis antigens have shown that recombinant proteins can induce both humoral and cellular immune responses .

• Vaccine Formulation Considerations:

  • Adjuvant selection is critical for enhancing immunogenicity:

    • Oil-in-water emulsions for strong antibody responses

    • CpG or other TLR agonists for balanced Th1/Th2 responses

    • Mucosal adjuvants for enhanced respiratory tract immunity

  • Combination with other antigens has shown improved protection in H. parasuis vaccines:

    • Outer membrane proteins (OmpP2, OmpP5, OmpD15)

    • Transferrin-binding proteins (TbpB) which have shown promising protection

    • Combination with GmhA and LpxC has demonstrated enhanced protection in mouse models

• Delivery System Options:

  • Purified recombinant protein formulation

  • DNA vaccine encoding atpD

  • Viral vector systems expressing atpD

  • Bacterial vector systems for mucosal delivery

• Protection Assessment:

  • Challenge studies in pigs using virulent H. parasuis serovar 5

  • Cross-protection evaluation against heterologous serovars

  • Previous studies with individual H. parasuis antigens have shown protection rates of 50-60% in mouse models, with higher rates for antigen combinations .

The primary challenge in developing atpD as a vaccine candidate would be confirming that immune responses against this highly conserved protein do not cross-react with host ATP synthase components, potentially causing adverse effects. Careful epitope selection and validation would be necessary to ensure safety and efficacy.

How can researchers investigate potential structural and functional differences between atpD proteins from virulent and avirulent H. parasuis strains?

Investigating structural and functional differences between atpD proteins from virulent and avirulent H. parasuis strains requires a multidisciplinary approach:

• Sequence Analysis and Comparison:

  • Multiple sequence alignment of atpD from virulent and avirulent strains

  • Identification of sequence variations in different domains

  • Phylogenetic analysis to determine evolutionary relationships

  • Correlation of sequence variants with virulence phenotypes

• Structural Biology Approaches:

  • Homology modeling based on crystal structures of ATP synthase β subunits from other species

  • X-ray crystallography of recombinant atpD proteins from different strains

  • Molecular dynamics simulations to investigate dynamic structural differences

  • Small-angle X-ray scattering (SAXS) for solution structure comparison

• Biochemical Characterization:

  • ATPase activity assays comparing enzymes from different strains

  • Nucleotide binding affinity measurements

  • Thermal stability analysis using differential scanning fluorimetry

  • Catalytic kinetics comparison (Km, Vmax, substrate specificity)

• Protein-Protein Interaction Studies:

  • Pull-down assays to identify differential binding partners

  • Surface plasmon resonance to quantify interaction affinities

  • Cross-linking studies to map interaction interfaces

  • Co-immunoprecipitation from bacterial lysates

• Functional Genomics Approaches:

  • Generation of chimeric proteins with domains swapped between virulent and avirulent strains

  • Complementation studies in atpD-deficient strains

  • Site-directed mutagenesis of identified variant residues

  • Gene expression analysis under different conditions

These approaches would help determine whether differences in atpD contribute to virulence or are simply markers of phylogenetic diversity. If functional differences are identified, they could potentially be exploited for the development of strain-specific diagnostics or targeted antimicrobial strategies.

What are the optimal protocols for evaluating the enzymatic activity of recombinant H. parasuis atpD?

Evaluating the enzymatic activity of recombinant H. parasuis atpD presents specific technical challenges since atpD functions as part of the multisubunit ATP synthase complex. Several methodological approaches can be employed:

• ATP Hydrolysis (ATPase) Activity:

  • Colorimetric assays based on phosphate release:

    • Malachite green assay for high sensitivity

    • Molybdate-based assays for higher throughput

  • Coupled enzyme assays:

    • Pyruvate kinase/lactate dehydrogenase system monitoring NADH oxidation

    • ADP-Glo™ assay measuring ADP production

  • Radiolabeled ATP assays for highest sensitivity

• Reaction Conditions Optimization:

  • Buffer composition screening:

    • pH range (typically 6.5-8.5)

    • Divalent cation requirements (Mg²⁺, Mn²⁺)

    • Salt concentration (50-200 mM)

  • Temperature optimization (25-42°C)

  • Substrate concentration range for kinetic parameters

• Catalytic Parameters Determination:

  • Km determination through Michaelis-Menten analysis

  • Vmax and kcat calculations

  • Inhibition studies with known ATP synthase inhibitors

  • Activation energy calculation through temperature dependence

• Reconstitution Approaches:

  • Co-expression with other F1 subunits (alpha, gamma, delta, epsilon)

  • In vitro reconstitution of partial or complete F1 complex

  • Liposome reconstitution for proton-pumping activity

• Biophysical Analysis of Nucleotide Binding:

  • Isothermal titration calorimetry (ITC)

  • Fluorescence-based binding assays

  • Surface plasmon resonance (SPR)

When interpreting activity data, it's important to consider that isolated atpD may have different properties compared to the native ATP synthase complex. Comparisons with well-characterized ATP synthase β subunits from other organisms can provide context for understanding the specific properties of H. parasuis atpD.

How can researchers develop effective epitope mapping strategies for H. parasuis atpD?

Epitope mapping of H. parasuis atpD requires a comprehensive approach combining computational prediction with experimental validation:

• In Silico Epitope Prediction:

  • B-cell epitope prediction tools:

    • BepiPred, ABCpred, Ellipro for linear epitopes

    • DiscoTope, PEPITO for conformational epitopes

  • T-cell epitope prediction:

    • NetMHCpan, IEDB Analysis Resource for MHC binding prediction

    • SYFPEITHI for processing and presentation prediction

  • Structural mapping of predicted epitopes on homology models

• Peptide-Based Experimental Mapping:

  • Overlapping peptide arrays covering the entire atpD sequence:

    • Typically 15-20 amino acid peptides with 5-10 residue overlap

    • SPOT synthesis on membranes or microarray platforms

  • ELISA with synthesized peptides against:

    • Sera from convalescent animals

    • Sera from vaccinated animals

    • Monoclonal antibodies if available

• Recombinant Fragment Approach:

  • Expression of discrete domains or fragments of atpD

  • Truncation libraries with systematic N- and C-terminal deletions

  • Domain-swapping with homologous proteins from non-pathogenic bacteria

• Monoclonal Antibody Generation and Characterization:

  • Immunization with full-length atpD or identified antigenic regions

  • Hybridoma development and screening

  • Epitope binning using competition assays

  • Fine mapping using mutagenesis or hydrogen-deuterium exchange

• T-cell Epitope Mapping:

  • Peptide stimulation of PBMCs from immune animals

  • Measurement of T-cell activation markers

  • Cytokine ELISpot assays (IFN-γ, IL-4, IL-17)

  • MHC-peptide binding assays

Epitope mapping data would be particularly valuable for vaccine development, allowing researchers to focus on immunodominant and protective epitopes while avoiding regions that might induce non-neutralizing or potentially cross-reactive antibodies.

What are the critical considerations for analyzing atpD sequence conservation across H. parasuis isolates and related species?

Analyzing atpD sequence conservation across H. parasuis isolates and related species requires a systematic approach with careful consideration of several factors:

• Sequence Acquisition and Quality Control:

  • Collection of atpD sequences from diverse sources:

    • Published genomes and databases

    • PCR amplification and sequencing from field isolates

    • Whole genome sequencing of representative strains

  • Quality assessment:

    • Coverage and read depth for sequenced regions

    • Verification of complete coding sequences

    • Assessment of sequence quality scores

• Multiple Sequence Alignment Strategies:

  • Algorithm selection based on sequence characteristics:

    • MUSCLE or MAFFT for closely related sequences

    • T-Coffee or CLUSTALW for more divergent sequences

  • Alignment parameters optimization:

    • Gap opening and extension penalties

    • Substitution matrices appropriate for the level of conservation

  • Manual curation and refinement of alignments

• Conservation Analysis Methods:

  • Calculation of sequence identity and similarity matrices

  • Sliding window analysis to identify variable and conserved regions

  • Identification of signature sequences for different serovars

  • Selection pressure analysis (dN/dS ratios) to identify regions under evolutionary constraint

• Structural Context Integration:

  • Mapping conservation patterns onto 3D structural models

  • Identification of surface-exposed variable regions

  • Assessment of conservation in functional domains:

    • Catalytic sites

    • Nucleotide-binding regions

    • Subunit interaction interfaces

• Phylogenetic Analysis:

  • Model selection for phylogenetic reconstruction

  • Tree-building methods (Maximum Likelihood, Bayesian inference)

  • Bootstrap or posterior probability assessment for branch support

  • Comparison with phylogenies based on other genetic markers

The analysis of atpD conservation would provide valuable insights for:

• Understanding the evolutionary history of H. parasuis

• Developing broadly cross-reactive diagnostic tools

• Identifying conserved regions as potential vaccine targets

• Understanding the relationship between sequence variation and virulence

How can recombinant H. parasuis atpD be utilized in diagnostic test development?

Recombinant H. parasuis atpD has significant potential for diagnostic test development, leveraging its conserved nature and immunogenicity:

• Serological Diagnostic Applications:

  • ELISA development using purified recombinant atpD:

    • Indirect ELISA for antibody detection in pig serum

    • Competitive ELISA for increased specificity

    • Isotype-specific ELISA to distinguish IgG/IgA responses

  • Lateral flow immunoassays for field-applicable point-of-care testing

  • Multiplex bead-based assays combining atpD with other antigens for comprehensive serological profiling

• Molecular Diagnostic Applications:

  • PCR primer design targeting conserved regions of atpD

  • Real-time PCR assays for quantitative detection

  • LAMP (Loop-mediated isothermal amplification) for field-deployable molecular testing

  • Multiplex PCR panels including atpD and other targets for comprehensive pathogen detection

• Validation and Performance Assessment:

  • Sensitivity determination using serial dilutions of known positive samples

  • Specificity evaluation against other Pasteurellaceae and respiratory pathogens

  • Reproducibility testing across different laboratories

  • Field validation studies in diverse geographical regions

• Clinical Applications:

  • Surveillance testing in pig herds

  • Differentiation of vaccinated from infected animals (DIVA strategy)

  • Monitoring immune responses to vaccination

  • Epidemiological studies of H. parasuis serovar distribution

The development of atpD-based diagnostics would require thorough validation against current gold standard methods and assessment of performance in field conditions. The highly conserved nature of atpD across H. parasuis strains makes it particularly suitable for broad detection approaches, while careful assay design would be needed to ensure specificity against related Pasteurellaceae species.

What future research directions could enhance our understanding of H. parasuis atpD's role in bacterial physiology and pathogenesis?

Several promising research directions could significantly advance our understanding of H. parasuis atpD's role in bacterial physiology and pathogenesis:

• Genetic Manipulation Studies:

  • Development of conditional atpD mutants (as complete deletion may be lethal)

  • CRISPR-Cas9 genome editing for precise modification of atpD

  • Site-directed mutagenesis of catalytic residues to create attenuated strains

  • Complementation studies to confirm phenotypic observations

  • Fluorescent protein fusions to track atpD localization

• Host-Pathogen Interaction Studies:

  • Investigation of atpD expression dynamics during infection

  • Transcriptomic and proteomic analysis under infection-relevant conditions

  • Evaluation of potential non-canonical roles beyond ATP synthesis

  • Assessment of atpD contribution to survival in different host niches

  • Determination of potential interactions with host factors

• Structural Biology Approaches:

  • High-resolution structure determination of H. parasuis atpD

  • Cryo-EM studies of the entire ATP synthase complex

  • Structural comparison between virulent and avirulent strain atpD

  • Structure-guided drug design targeting unique features

  • Conformational dynamics studies during the catalytic cycle

• Systems Biology Integration:

  • Metabolomic profiling of wild-type vs. atpD-modulated strains

  • Network analysis of atpD interactions with other cellular processes

  • Mathematical modeling of energy metabolism during infection

  • Integration of transcriptomic, proteomic, and metabolomic data

• Translational Research Directions:

  • Development of atpD-based subunit vaccines with novel adjuvants

  • Screening for small molecule inhibitors targeting unique features of H. parasuis atpD

  • Exploration of atpD as a carrier protein for epitope delivery in vaccine design

  • Combination studies with other protective antigens

These research directions would provide a comprehensive understanding of atpD's role in H. parasuis biology and potentially identify novel approaches for intervention against Glässer's disease in pigs. Integration of traditional microbiology with cutting-edge technologies would offer the most complete picture of this important bacterial protein.